Unknown

Dataset Information

0

Rapid diagnosis of medulloblastoma molecular subgroups.


ABSTRACT: PURPOSE:Microarray studies indicate medulloblastoma comprises distinct molecular disease subgroups, which offer potential for improved clinical management. EXPERIMENTAL DESIGN:Minimal mRNA expression signatures diagnostic for the Wnt/Wingless (WNT) and Sonic Hedgehog (SHH) subgroups were developed, validated, and used to assign subgroup affiliation in 173 tumors from four independent cohorts, alongside a systematic investigation of subgroup clinical and molecular characteristics. RESULTS:WNT tumors [12% (21/173)] were diagnosed >5 years of age (peak, 10 years), displayed classic histology, CTNNB1 mutation (19/20), and associated chromosome 6 loss, and have previously been associated with favorable prognosis. SHH cases [24% (42/173)] predominated in infants (<3 years) and showed an age-dependent relationship to desmoplastic/nodular pathology; all infant desmoplastic/nodular cases (previously associated with a good outcome) were SHH-positive, but these relationships broke down in noninfants. PTCH1 mutations were common [34% (11/32)], but PTCH1 exon1c hypermethylation, chromosome 9q and REN (KCTD11) genetic loss were not SHH associated, and SMO or SUFU mutation, PTCH1 exon1a or SUFU hypermethylation did not play a role, indicating novel activating mechanisms in the majority of SHH cases. SHH tumors were associated with an absence of COL1A2 methylation. WNT/SHH-independent medulloblastomas [64% (110/173)] showed all histologies, peaked at 3 and 6 years, and were exclusively associated with chromosome 17p loss. CONCLUSIONS:Medulloblastoma subgroups are characterized by distinct genomic, epigenomic and clinicopathologic features, and clinical outcomes. Validated array-independent gene expression assays for the rapid assessment of subgroup affiliation in small biopsies provide a basis for their routine clinical application, in strategies including molecular disease-risk stratification and delivery of targeted therapeutics.

SUBMITTER: Schwalbe EC 

PROVIDER: S-EPMC3071325 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid diagnosis of medulloblastoma molecular subgroups.

Schwalbe Ed C EC   Lindsey Janet C JC   Straughton Debbie D   Hogg Twala L TL   Cole Michael M   Megahed Hisham H   Ryan Sarra L SL   Lusher Meryl E ME   Taylor Michael D MD   Gilbertson Richard J RJ   Ellison David W DW   Bailey Simon S   Clifford Steven C SC  

Clinical cancer research : an official journal of the American Association for Cancer Research 20110216 7


<h4>Purpose</h4>Microarray studies indicate medulloblastoma comprises distinct molecular disease subgroups, which offer potential for improved clinical management.<h4>Experimental design</h4>Minimal mRNA expression signatures diagnostic for the Wnt/Wingless (WNT) and Sonic Hedgehog (SHH) subgroups were developed, validated, and used to assign subgroup affiliation in 173 tumors from four independent cohorts, alongside a systematic investigation of subgroup clinical and molecular characteristics.<  ...[more]

Similar Datasets

| S-EPMC4819007 | biostudies-literature
| S-EPMC4677409 | biostudies-literature
| S-EPMC6330121 | biostudies-literature
| S-EPMC3953419 | biostudies-literature
| S-EPMC4896550 | biostudies-literature
| S-EPMC6163053 | biostudies-literature
| S-EPMC3948094 | biostudies-literature
| S-EPMC3519926 | biostudies-literature
| S-ECPF-GEOD-37418 | biostudies-other